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Abstract
To develop magnetic resonance imaging (MRI) indicators to predict trismus outcome for post-operative oral cavity cancer
patients who received adjuvant intensity-modulated radiation therapy (IMRT), 22 patients with oral cancer treated with
IMRT were studied over a two-year period. Signal abnormality scores (SA scores) were computed from Likert-type ratings of
the abnormalities of nine masticator structures and compared with the Mann-Whitney U-test and Kruskal–Wallis one-way
ANOVA test between groups. Seventeen patients (77.3%) experienced different degrees of trismus during the two-year
follow-up period. The SA score correlated with the trismus grade (r=0.52, p,0.005). Patients having progressive trismus
had higher mean doses of radiation to multiple structures, including the masticator and lateral pterygoid muscles, and the
parotid gland (p,0.05). In addition, this group also had higher SA-masticator muscle dose product at 6 months and SA
scores at 12 months (p,0.05). At the optimum cut-off points of 0.38 for the propensity score, the sensitivity was 100% and
the specificity was 93% for predicting the prognosis of the trismus patients. The SA score, as determined using MRI, can
reflect the radiation injury and correlate to trismus severity. Together with the radiation dose, it could serve as a useful
biomarker to predict the outcome and guide the management of trismus following radiation therapy.
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Introduction
Trismus is one of the sequela for head and neck cancer patients.
The prevalence of trismus after head and neck oncology treatment
could be as high as 42% [1]. It has been described as any type of
restriction in the opening of the mouth including radiation and
conditions after trauma, surgery, or tetanus [2,3,4]. Radiation
therapy involving the temporomandibular joint (TMJ), pterygoid
muscles, and the temporalis or the masseter muscle is most likely to
result in trismus [5,6]. Moreover, there may be scar tissue from
radiation, surgery, nerve damage, or a combination of these
factors to cause trismus [6,7]. Further, doses of radiotherapy (RT)
in excess of 60 Gy [8] or the configuration of the radiation field
increasing [9] are more likely to cause trismus.
Recently, extensive data suggest intensity-modulated radiation
therapy (IMRT) is safe and efficacious in the adjuvant setting for
oral cavity cancer (OCC) [10,11,12]. Hsiung et al. [13] and Chen
et al. [14] noted radiation induced trismus for nasopharyngeal
carcinoma patients progressed over time and improved by IMRT.
Louise et al. [15] noted when doses of massetor or pterygoid
muscles larger than 55 Gy were given, the incidences of trismus
for head and neck patients were as high as 45%. With every
additional 10 Gy to the pterygoid muscle, the increase in the
probability of trismus was 24% [5].
Magnetic resonance imaging (MRI) can display abnormal
image findings in masticator structures for patients with trismus
developing after radiotherapy for nasopharyngeal carcinoma
(NPC) [6]. However, in this report, the image findings showed
no correlation between the severity of trismus and radiation
dosage [6]. Moreover, aggressive interventions should be given to
the patient whose trismus does not improve as time passes.
PLOS ONE | www.plosone.org 1 March 2014 | Volume 9 | Issue 3 | e92561However, there is still no good indicator to predict the outcome of
trismus developing after radiotherapy.
The purpose of this study is to use MRI to predict the severity of
trismus and evaluate the correlation of images and radiation
dosage between related structures concerning trismus. We also
tried to find the prognostic factors of trismus developing after the
operation and IMRT for oral cancer patients.
Materials and Methods
Patient characteristics
This retrospective study was approved by the Institutional
Review Board (IRB) of the Far Eastern Memorial Hospital
(FEMH-IRB-101127-F) and Clinical Trials government with
number of NCT02004639. Patient consents were specifically
waived because the data were analyzed anonymously and
approval was given by the IRB. Patient confidentiality and privacy
were protected according to national standards. Between Decem-
ber 2006 and December 2012, patients with OCC squamous cell
carcinoma (SCC) who had undergone surgery followed by
postoperative IMRT with or without chemotherapy at Far
Eastern Memorial Hospital were enrolled. Patients who were
treated for recurrent SCC of the oral cavity (including neck
recurrences), follow-up time less than 2 years, incomplete trismus
grading records or incomplete MRI image studies were excluded
from the analysis. The disease was staged according to the
American Joint Committee on Cancer Staging Classifications 6
th
edition, which was based on the pathological findings after radical
surgery.
Radiation therapy
A 7-filed IMRT or helical tomotherapy, image-guided IMRT,
with daily fractions of 1.8 or 2 Gy in five consecutive days were
used. It encompassed the preoperative gross tumor and postop-
erative flap plus a 0.8- to 1-cm margin, including the resection bed
with soft-tissue invasion by the tumor or extra-capsular extension
(ECE) that received 60–66 Gy in 30–33 fractions; 64–66 Gy was
delivered to high-risk OCC patients and 60 Gy was delivered to
intermediate-risk OCC patients. For the high-risk subclinical area,
59.4–60 Gy/30–33 fractions were delivered and for the low-risk
area of potential subclinical disease, 51.2–54 Gy/30–33 fractions
were delivered [16]. The grading of trismus in the clinical results
was from grade one to three according to the Common
Terminology Criteria for Adverse Events (CTCAE) v3.0. The
Figure 1. Describe the trismus related muscles and structures
that were targeted by colors in one of enrolled patients. Light
blue: left side medial pterygoid muscle; Pink: left side lateral pterygoid
muscle; Light orange: left side temporalis; Forest green: left side
masseter; Steel blue: left side temporomandibular joints. Sky blue: right
side medial pterygoid muscle; Yellow: right side lateral pterygoid
muscle; Yellow green: right side temporalis; Orange: right side masseter;
Purple: right side temporomandibular joints.
doi:10.1371/journal.pone.0092561.g001
Table 1. Signal Abnormality Score in different masticator structures.
Anatomy SA Score
01 2
Masticator Muscles
Medial pterygoid
Lateral Pterygoid
Masseter Normal T2 signal change T2 signal change with abnormal enhancement
Temporalis
Masticator atrophy Normal Part of masticator muscle atrophy All muscles atrophy
Temporomandibular Joint
Deformity Normal Mild Severe
Ramus ORN Normal Signal change Bone destruction
Other Structures
Perimasticator space Normal Inflammation change Fibrosis
Parotid gland Normal Abnormal enhancement Atrophy
Abbreviation.
SA score = Signal Abnormality score; ORN = Osteoradionecrosis.
doi:10.1371/journal.pone.0092561.t001
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parotid gland, mandibular rami and temporomandibular joints
(TMJ) were targeted and calculated by dose-volume histogram for
those enrolled patients retrospectively (Fig. 1).
Evaluation of MRI examinations
MRI results at 6
th months, 12
th months and 24
th months after
initiation of radiation treatment were selected for analysis. These
data were assessed by two radiologists blind to their clinical
information and trismus severity. The MRI imaging protocols
applied at our institution for patients with oral cancer include axial
T1 weighted image (T1W), coronal T2 weighted image (T2W),
axial T2W with fat saturation, sagittal, coronal T1W post-
gadolinium and axial T1W post-gadolinium with fat saturation
sequences. TIW and T2W are both conventional image sequences
applied in daily MRI examination. In practice, T1W and T2W
image are where the contrast depends predominantly on the
differences in the T1 times and T2 times between tissues e.g. fat
and water, respectively [17]. Tl describes the interaction of excited
Table 2. Patient characteristics.
Enrolled patients (No.=22)
Variable No. of patients (%)
Age (years)
Mean 50
Range 38–71
Gender
Male 20 (94.3%)
Female 2 (5.7%)
Subsite
Oral tongue 8 (36.4%)
Buccal mucosa 12 (54.5%)
Lip 1 (4.5%)
Gum 1 (4.5%)
Pathology
Squamous cell carcinoma 22 (100%)
Tumor stage
Stage I 1 (4.5%)
Stage II 1 (4.5%)
Stage III 7 (31.8%)
Stage IVA 13 (59.1%)
Stage IVB 0
Primary tumor stage
T1 2 (9.1%)
T2 5 (22.7%)
T3 7 (31.8%)
T4a 8 (36.4%)
T4b 0
Regional lymph node stage
N0 9 (40.9%)
N1 4 (18.2%)
N2a 0
N2b 8 (36.4%)
N2c 1 (4.5%)
N3 0
Adjuvant concurrent chemotherapy
Yes 20 (90.9%)
No 2 (9.1%)
RT dose
Median (range) 64 Gy (59.8–70 Gy)
Mean dose of
Right temporomandibular joint 24.8616.9 (Gy)
Right masseter muscle 37.3615.9 (Gy)
Right temporalis 19.8614.0 (Gy)
Right medial pterygoid muscle 52.6613.1 (Gy)
Right lateral pterygoid muscle 40.8616.3 (Gy)
Right parotid gland 30.1611.4 (Gy)
Left temporomandibular joint 28.3621.6 (Gy)
Left masseter muscle 39.4618.4 (Gy)
Left temporalis 21.2616.9 (Gy)
Left medial pterygoid muscle 52.6613.1 (Gy)
Table 2. Cont.
Enrolled patients (No.=22)
Variable No. of patients (%)
Left lateral pterygoid muscle 41.85617.0 (Gy)
Left parotid gland 34.9614.9 (Gy)
doi:10.1371/journal.pone.0092561.t002
Figure 2. Illustrated T1W MRI post-contrast enhancement of
trismus patient after RT. (a) Coronal view with fat saturation showed
radiation effects in right lateral (white arrows), medial (black arrows)
pterygoid muscles and masseter muscle (white arrowhead) with
increased enhancement. (b) Coronal view showed atrophic change of
the right lateral (white arrows), medial (black arrows) pterygoid muscles
and masseter muscle (white arrowhead). (c) Axial view with fat
saturation showed remarkable fibrotic tissue (white arrow) occupying
right maxillary sinus and pterygoid space. (d) Axial view with fat
saturation showed increased enhancement with atrophic change of the
right parotid gland. All these findings were rated as point 2 according
to our Likert scoring system of signal abnormality (SA score).
doi:10.1371/journal.pone.0092561.g002
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describes the interaction of excited nuclear spins with the spins of
other nuclei (spin-spin relaxation) [18].
Signal abnormality scores (SA score) were rated with a Likert
scoring system [19]. A three-point Likert item SA score was used
in the current study, and the structures analyzed were listed in
table 1. For evaluation of the masticator muscles, we rated the
signal change as ‘‘0’’= normal; ‘‘1’’=T2 signal change only;
‘‘2’’=1 plus muscle atrophy or obvious abnormal enhancement
on T1W post-gadolinium sequences. While rating the perimasti-
cator space, ‘‘0’’= normal; ‘‘1’’=T2 signal change only, ‘‘2’’=1
plus fibrosis tissue formation or abnormal enhancement. For
chronic injury of the mandibular division of the trigeminal nerve,
which was inferred if there was atrophy of all ipsilateral masticator
muscles as well as of the mylohyoid and anterior belly of the
digastric muscles, we rated atrophy of part of these muscles as ‘‘1’’
and complete atrophy of all muscles as ‘‘2’’. In the parotid gland,
only signal change was rated as ‘‘1’’ and obvious gland atrophy
was rated as‘‘2’’. These abnormalities were differentiated from
residual tumor by their signal characteristics and static appearance
on serial imaging.
Method of analysis
At first, groups according to trismus grade in CTCAE v3.0 were
separated and compared using Kruskal–Wallis one-way ANOVA
test without assuming parametric distribution. The correlation
between the SA score and trismus grade, or the SA score and the
radiation dose of individual masticator structures were tested by
Spearman’s correlation test. Statistically significant SA scores were
used as independent variables, and determined as useful in
predicting the severity of trismus. Using the SA scores found to be
useful, the function of logistic regression was calculated and the
receiver-operating characteristic (ROC) curve was generated to
find an optimum cut-off for predicting trismus severity.
After that, the patients were re-separated into two groups
according to their trismus condition. One was the ‘‘good
prognosis, GP’’ group if patient’s trismus grade improved in time
sequence or as normal. The other was ‘‘poor prognosis, PP’’ group
if patient’s trismus remained stable or got worsened during the two
year follow up. The SA scores at 6
th months, 12
th months, the
radiation dose of all and individual masticator structures, along
with the product of the SA score with mean radiation dose of
masticator muscles (SA score6mean radiation dose of masticator
muscles for specific interesting) were all compared between these
two groups. All data were evaluated with the non-parametric
Mann-Whitney U-test without assuming parametric distribution.
The statistically significant variables were used as independent
factors, and only the ones showing statistical significance were
determined as useful in predicting the incidence of poor prognosis
trismus. Utilizing the function of logistic regression, propensity
score was sought for estimating the incidence of poor prognosis
trismus among all the subjects during the follow-up period [18].
All the above statistical analyses were performed using Prism
(release 6.0, GraphPad Software Inc. La Jolla, CA, USA) and
SPSS (IBM Corp. Released 2012. IBM SPSS Statistics for
Windows, Version 21.0. Armonk, NY) and a P value equal or
less than 0.05 was considered statistically significant.
Results
Totally, 87 patients were enrolled but sixty-five cases were
excluded due to incomplete clinical information or incomplete
imaging data. Twenty-two cases with a total of sixty-six MRI
exams were enrolled in this study. Table 2 lists the characteristics
of the patients. The mean age was 50 years old, consisting of
twenty men and two women. The dominant subgroups were
buccal cancer (54.5%) and tongue cancer (36.4%). Ninety percent
were stage III and IV. The median radiation dose was 64 Gy.
Seventeen patients (77.3%) experienced different degrees of
trismus during two year follow up after IMRT.
Figure 3. Comparison of signal abnormality scores between different groups of trismus severity. Significant difference in the SA scores
between groups is noted (p=.03). The grade 3 group (most severe one) has the highest score and the grade 1 (least severe one) group has the lowest
score.
doi:10.1371/journal.pone.0092561.g003
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masticator muscle signal abnormality (Fig. 2a and 2b). Within
them, denervation atrophy of the masticator muscles secondary to
mandibular nerve damage (6/22, 9.0%), mild osteoradionecrosis
change of mandibular rami (10/22, 15.2%), and perimasticator
fibrosis extending into the masticator space totaled six (9.0%,
Fig. 2c). Post RT damage of the parotid glands was 63.6% (Fig. 2d).
The mean SA scores of the grade 1, 2 and 3 group are 4.8761.9,
6.163.2 and 8.560.7, respectively. Significant differences between
groups (Fig. 3, p=.03, one-way ANOVA test) were noted.
Additionally, there was a significant positive correlation between
SA score and trismus grading (r=0.52, p,0.005) to predict the
severity of trismus. In addition, the SA score of the trismus group
(6.2063.1, group of grade 2 and grade 3) was higher than that of
the non-trismus group (4.8761.9, grade 1 group, p=.04). The
ROC curve was then generated using the values of the SA scores
from the non-trismus (grade 1) and trismus (grade 2 plus grade 3)
groups. The best cut-off values of the SA score that maximizes
(sensitivity + specificity) were 5.5, with 64% sensitivity and 61%
specificity.
There was a positive correlation between the dose of the
individual masticator structures and the two year SA scores
summation (r=0.48, p,0.0001; Fig. 4a). Furthermore, the SA
score gradually decreased along with clinical trismus grade and
time sequence (Fig. 4b).
There were significant differences between PP and GP groups in
the mean dose of masticator structures (39.669.3 vs 33.367.1,
p=.04; Fig. 5a), masticator muscles (40.0610.1 vs 33.767.4,
p=.05; Fig. 5b), lateral pterygoid muscle (46.8617.3 vs
37.8611.8, p=.04; Fig. 5c), parotid gland (37.1614.3 vs
29.8610.7, p=.01; Fig. 5c), and the product of six month SA
scores with mean masticator muscle dose (269.66126 vs
186.2697.0, p=.04; Fig. 5d) and twelve month SA scores
(7.362.8 vs 4.661.6, p=.01; Fig. 5e). There was no significant
difference in six month SA scores, radiation dose of medial
pterygoid muscle, masseter muscle, and the temporalis muscle
between the PP and GP groups (Fig. 5c). However, there was a
trend for the mean dose of TMJ to influence both groups (p=.06).
The best cut-off values of the above data that maximized
sensitivity and specificity were obtained and listed in table 3. The
functional formula for predicting the incidence of poor prognosis
trismus, i.e. propensity score, came out as follows:
Propensity score =1/(1+1/exp (mean dose of masticator
structures 63.576+ mean dose of masticator muscles 623.284+
lateral pterygoid muscle dose 6 0.138+ parotid gland dose 6
20.296+ the product of 6
th month SA scores with mean
masticator muscle dose 60.001+12
th month SA scores 6
1.281212.654)).
The area-under-curve (AUC) was 0.93 for propensity score and
the optimum cut-off points were 0.38. By applying the cut-off
value, we achieved 100% sensitivity and 93% specificity to predict
the prognosis of these trismus patients (Table 3).
Discussion
In the current study, there is a good correlation between the
MRI SA score with trismus severity (r=0.52, p,0.005) and the
received radiation dose (r=0.48, p,0.0001). Several prognostic
factors of trismus were also detected with signifcant differences
between trismus improving and worsening patients, which were
the mean dose of the masticator structures (p=.04), masticator
muscles (p=.05), lateral pterygoid muscle (p=.04), parotid gland
(p=.01), the product of six month SA scores with the mean
masticator muscle dose (p=.04), and twelve month SA scores
(p=.01). With the optimum cut-off points as 0.38 for the
propensity score, we achieved 100% sensitivity with 93%
specificity to predict the prognosis of these trismus patients.
Trismus is a well known complication of head and neck cancer
treatment [9,20]. In a previous study, 35 NPC patients completed
RT treatment with trismus with a dental gap less than 2.5 cm
being studied by retrospective MRI analysis [6]. Fifty-four percent
of them had abnormalities in several structures involved with
mastication, without mentioning the correlation between RT
doses. Several previous studies reported a direct correlation
between RT dose of the masticator muscles and subsequent
reductions in the dental gap [21,22,23]. Dijkstra et al [5] also
reported reduced mouth opening of 18% in patients treated by RT
involving the structures of the TMJ and/or pterygoid muscles.
Similar conditions were also noted in our OCC patients who
received RT or CCRT. In the current study, several abnormalities
of the masticator muscles were noted by MRI, suggesting trismus
is a multifactorial disease. Additionally, there was a strong
correlation between the two year SA score summation with the
radiation dose received by individual masticator structures
(r=0.48, p,0.0001). This meant our SA score can reflect the
radiation dose received by each individual masticator structures
and also implied the radiation-induced fibrosis or injury of OCC
patients can be revealed by MRI and quantified by our scoring
system.
Figure 4. Correlation of SA score with radiation dose and the
time trend of trismus development. (a) Correlation of the received
radiation dose of individual masticator structures with their two year SA
scores summation (r=0.48, p,0.0001). (b) Evolution of the SA scores
and the trismus grade over time. Gradual decrease of trismus severity
grade (.) and SA scores (%) is noted within 24 months.
doi:10.1371/journal.pone.0092561.g004
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good correlation (r=0.52, p,0.005) with the clinical trismus
severity, hinting that the severity of trismus could be predicted by
imaging. According to the results of the ROC curve, patients
experiencing some degree of trismus-related impaired eating could
be predicted with an SA score higher than 5.5 (with 64%
sensitivity and 61% specificity respectively). This suggests the SA
score may serve as an imaging predictor of trismus and may also
reflect the degree of underlying pathological changes. Moreover,
the SA score gradually decreased along with clinical trismus grade
Figure 5. Comparison of radiation doses and SA scores between good prognosis and poor prognosis trismus groups. A significant
difference is noted in the mean dose of masticator structures (p=.04; Fig. 5a), mean dose of masticator muscles (p=.05; Fig. 5b), mean dose of lateral
pterygoid muscles (p=.04; Fig. 5c), mean dose of parotid glands (p=.01; Fig. 5c), the product of the six month SA score with mean masticator
muscles dose (p=.04; Fig. 5d) and the twelve month SA score (p=.01; Fig. 5e). (MP: medial pterygoid muscle; LP: lateral pterygoid muscle; Temp:
temporalis muscle; TMJ: temporomandibular joint; PG: parotid gland; SA score: signal abnormality score; GP: good prognosis; PP: poor prognosis).
doi:10.1371/journal.pone.0092561.g005
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that most radiation-induced trismus patients after IMRT will
gradually improve over time. This implies the SA score can be
applied as an indicator of treatment response in trismus during
follow up.
Our results also revealed some trismus subsided over time, but
some did not. For the patient whose trismus will not improve as
time goes by, a more aggressive treatment plan including
rehabilitation exercise [24], Botox injection or even surgical
intervention [25] should be suggested as early as possible.
Therefore, it is critical to find the prognostic factors of trismus
after RT to help physicians and patients overcome this sequela. In
the current study, the six factors correlated with prognosis were the
mean dose of masticator structures, masticator muscles, lateral
pterygoid muscle, parotid gland, the product of six month SA
scores with mean dose of masticator muscles and the twelve month
SA scores. Here, we also found the radiation dose of the parotid
glands plays a role in trismus prognosis. This may due to the fact
that the anatomical correlation between parotid glands and
masticator structures influences the dose distribution in RT plan.
According to our model, applying the optimum cut-off point of the
propensity score at 0.38, we are able to pick out poor-prognostic
trismus patients with 100% sensitivity and 93% specificity, which
is better than predicted by radiation dose (sensitivity and specificity
around 63%/90%). So it considers more factors and thus has
better prediction strength. Therefore, in terms of improving the
validity of screening, we recommend using all six of these
parameters together rather than any one of them alone to
enhance the detection of poor prognosis trismus.
If the doses of massetor or pterygoid muscles are larger than
55 Gy, the incidences of trismus for head and neck patients were
as high as 45% [15]. Additionally, there is an increased probability
of trismus of 24% with every additional 10 Gy to the pterygoid
muscle [5]. Practically, according to the previous report and data
revealed here, the constraints of the masticator structures would be
better below the cut-off values, emphasizing the lateral pterygoid
muscle (42 Gy) and parotid gland (28 Gy). For those cases who
cannot achieve this goal, the patients would experience a high risk
of developing poor-prognosis trismus and some preventive
management should be given. Further, if the product of six
month SA scores with the mean dose of masticator muscles or the
twelve month SA score itself exceeds the proposed cut-off at the 6
th
or 12
th month follow-up after RT, aggressive treatment or
intervention for the trismus should be prescribed to facilitate
disease improvement.
There are some limitations to the current study. First, due to the
nature of retrospective study, we were unable to match the age and
gender in each of our groups. In addition, we did not measure the
mean incisor distance of each patient and the trismus severity
grading system we used may be affected by other factors. Finally,
the patients enrolled in the current study should experience post-
RT period for more than 2 years due to the deterioration of
radiation-induced trismus occurring within 24 months after RT
limited the number of patients. All these factors could possibly
cause some bias in our results.
MRI SA score and the radiation dose of masticators muscles are
useful in predicting trismus severity per se and its prognosis in
OCC patients after RT or CCRT. Though more investigations
are mandatory to validate our results, the radiation and imaging
parameters may serve as a powerful tool to guide the management
of trismus after radiation therapy. In addition, one may prevent
the development of poor-prognostic trismus by the constraints
suggested here, especially on the lateral pterygoid muscles and also
parotid glands. If the radiation dose of specific structures or the SA
scores at six and twelve months are higher than the proposed
cutoffs, more aggressive treatment for trismus is suggested. Long-
term follow-up and large prospective studies are needed to confirm
these preliminary findings.
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Table 3. The incidence of poor prognosis trismus predicts by cut-off values of masticator structures, time schedual SA score and
propensity score.
Cutoff Values from ROC curve results
Data Set Cutoff Value Sensitivity (%) Specificity (%)
Mean Radiation Dose of masticator structures 42.14 63.64 90
Mean Radiation Dose of masticator muscles 42.54 63.64 90
Mean Radiation Dose of LP 42.03 72.73 70
Mean Radiation Dose of PG 27.99 80.95 60
6
th month SA score 6mean masticator muscle dose 240.6 72.73 90
12
th month SA score 5.5 72.73 72.73
Propensity Score* 0.38 100 91
Abbreviation.
LP = lateral pterygoid muscle; PG = parotid gland; ROC curve = receiver operating characteristic curve.
*The propensity score was generated from the above six parameters with logistic regression analysis.
doi:10.1371/journal.pone.0092561.t003
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